menu
    • menu

    Company profile for Herantis Pharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Herantis Pharma is a publicly listed (HRTIS) drug development company aiming to revolutionize the treatment of diseases with unmet clinical needs. Based on leading academic research published in high-impact journals including Nature and Science, the two ongoing clinical development programs explore the potential of our novel drug candidates in Parkinson’s disease and secondary lymphedema. For Parkinson’s disease, our neuro...
    Herantis Pharma is a publicly listed (HRTIS) drug development company aiming to revolutionize the treatment of diseases with unmet clinical needs. Based on leading academic research published in high-impact journals including Nature and Science, the two ongoing clinical development programs explore the potential of our novel drug candidates in Parkinson’s disease and secondary lymphedema. For Parkinson’s disease, our neuroprotective and neurorestorative drug candidate CDNF is intended to become the first disease-modifying treatment with further potential in other neurodegenerative diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Herantis PharmaFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Bertel Jungin Aukio 1 FI-02600 Espoo
    Telephone
    Telephone
    +358 9 222 1196
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://herantis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/herantis-pharma-plc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/herantispharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Herantis Pharma Completes 6-Month GLP Toxicology Study On HER-096
    Herantis Pharma Completes 6-Month GLP Toxicology Study On HER-096

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3194991/0/en/Herantis-Pharma-announces-successful-completion-of-six-month-GLP-toxicology-study-of-HER-096.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Herantis Pharma Unveils Positive Phase 1B Data For HER-096
    Herantis Pharma Unveils Positive Phase 1B Data For HER-096

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162855/0/en/Herantis-Pharma-presents-positive-topline-data-for-HER-096-in-Phase-1b-trial-for-people-living-with-Parkinson-s-disease.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share
    Herantis Pharma Publishes 1H 2025 Report Today
    Herantis Pharma Publishes 1H 2025 Report Today

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3136831/0/en/Herantis-Pharma-releases-1H-2025-report-today.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share
    Phase 1b Trial of Her-096 for Parkinson's Disease Completes
    Phase 1b Trial of Her-096 for Parkinson's Disease Completes

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133545/0/en/Last-patient-visit-completed-on-schedule-in-Phase-1b-clinical-trial-of-HER-096-for-Parkinson-s-disease.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    HER-096 Trial for Parkinson’s Reaches Final Phase 1b Cohort
    HER-096 Trial for Parkinson’s Reaches Final Phase 1b Cohort

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3079769/0/en/First-patients-dosed-in-final-cohort-of-Phase-1b-clinical-trial-of-HER-096-for-Parkinson-s-disease.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share
    Herantis Pharma Plc Announces Topline Results of Phase 1-2 CDNF Trial
    Herantis Pharma Plc Announces Topline Results of Phase 1-2 CDNF Trial

    25 Feb 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/herantis-pharma-plc-announces-topline-results-of-phase-1-2-cdnf-trial-301010446.html

    PRNEWSWIRE
    25 Feb 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search